Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|October 11, 2004
PrairieStone rocks Twin Cities with automated pharmacies
The prairie stone is a rock that is indigenous to Minnesota, and it is also the stone used to create the mortar and pestle. So when it came to naming their new Minneapolis-based pharmacy chain, the company's three partners found it a no-brainer. They dubbed it PrairieStone Pharmacy.
Advertisement
Advertisement
Related to this article
Researchers outline individual peripheral arterial disease burden as well as the most at-risk patient populations and treatment recommendations.
Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Study findings tie continuous glucose monitoring measures to elevated cardiovascular risk in adults without diabetes.
The once daily tablet is expected to reach US patients in October 2026.
The label expansion adds patients 12 years of age and older to the once daily alopecia areata indication.
Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
Advertisement
Advertisement
Trending on Drug Topics
1
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
2
CDC Opens Orders for COVID-19 Vaccines in Vaccines for Children
3
CGM Data Links Glycemic Burden to Cardiovascular Risk Without Diabetes
4
FAQ: Pharmacist Understanding of mRNA Vaccine Technology
5